Atlas Trials

Dexmedetomidine-esketamine for Percutaneous Radiofrequency Liver Ablation

Clinical trial NCT06003218 · COMPLETED

Trial details

NCT number
NCT06003218
Sponsor
Peking University First Hospital
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Liver CancerRadiofrequency AblationEsketamineDexmedetomidine
Start date
2023-10-16
Primary completion
2024-09-26
Enrollment
88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.